Pleural fluid and peripheral eosinophilia from hemothorax: Hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax

American Journal of the Medical Sciences

Volumn 332, Issue 3, 2006, Pages 148-152

  Heidecker, Jay ^a   Kaplan, Allen ^a   Sahn, Steven A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Eosinophils; Hemothorax; Pleural effusion; Pneumothorax

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BLOOD; CASE REPORT; CHIROPRACTIC; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EOSINOPHILIA; HEMATOTHORAX; HUMAN; HYPEREOSINOPHILIA; LABORATORY TEST; MALE; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID; THORAX PAIN; THORAX RADIOGRAPHY;

ADULT; EOSINOPHILIA; HEMOTHORAX; HUMANS; MALE; PLEURAL EFFUSION; PNEUMOTHORAX;

EID: 33748749965     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200609000-00011     Document Type: Article

References (31)

1. Rothenberg ME. Eosinophilia. N Engl J Med 1998;338:1592-1600.
2. Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med 2003;9:254-60.
3. Nakamura Y, Ozaki T, Kamei T, et al. Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocyte/macrophage colony-stimulating factor, interleukin-5, and interleukin-3. Am J Respir Cell Mol Biol 1993;8:605-11.
4. Gregoire R, Courcoux A. Symptomes Des Plaies de la Plevre et du Poumon. In: Masson, ed. Plaies de la Plevre et du Poumon. Paris: Libraires de L'Academie de Medecine, 1917;60-84.
5. Adelman M, Albelda SM, Gottlieb J, et al. Diagnostic utility of pleural fluid eosinophilia. Am J Med 1984;77:915-20.
6. Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest 1996;110:1271-4.
7. Bynum LJ, Wilson JE 3rd. Radiographic features of pleural effusions in pulmonary embolism. Am Rev Respir Dis 1978;117:829-34.
8. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-9.
9. Smit HJ, van den Heuvel MM, Barbierato SB, et al. Analysis of pleural fluid in idiopathic spontaneous pneumothorax: correlation of eosinophil percentage with the duration of air in the pleural space. Respir Med 1999;93:262-7.
10. De Smedt A, Vanderlinden E, Demanet C, et al. Characterisation of pleural inflammation occurring after primary spontaneous pneumothorax. Eur Respir J 2004;23:896-900.
11. Saini JS, Lal M, Rai J. Eosinophilic pleural effusion following pneumothorax. Indian J Chest Dis Allied Sci 1980;22:133-6.
12. Spriggs A, Boddington M (eds). The Cytology of Effusions: Pleural, Pericardial and Peritoneal and of Cerebrospinal Fluid, 2nd ed. London: Heinemann, 1968.
13. Maltais F, Laberge F, Cormier Y. Blood hypereosinophilia in the course of posttraumatic pleural effusion. Chest 1990;98:348-51.
14. Mohamed KH, Abdelhamid AI, Lee YC, et al. Pleural fluid levels of interleukin-5 and eosinophils are closely correlated. Chest 2002;122:576-80.
15. Kalomenidis I, Mohamed KH, Lane KB, et al. Pleural fluid levels of vascular cell adhesion molecule-1 are elevated in eosinophilic pleural effusions. Chest 2003;124:159-66.
16. Southam DS, Widmer N, Ellis R, et al. Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice. J Allergy Clin Immunol 2005;115:95-102.
17. Kravetz JD, Federman DG. Valproic acid-induced eosinophilic pleural effusion. South Med J 2003;96:803-6.
18. Middleton KL, Santella R, Couser JI Jr. Eosinophilic pleuritis due to propylthiouracil. Chest 1993;103:955-6.
19. Milleron BJ, Valcke J, Akoun GM, et al. Isotretinoin-related eosinophilic pleural effusion. Chest 1996;110:28.
20. Bunker CB, Sheron N, Maurice PD, et al. Isotretinoin and eosinophilic pleural effusion. Lancet 1989;1:435-4.
21. Rosenow EC 3rd. Drug-induced bronchopulmonary pleural disease. J Allergy Clin Immunol 1987;80:780-7.
22. Holmberg L, Boman G. Pulmonary reactions to nitrofurantoin: 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976. Eur J Respir Dis 1981;62:180-9.
23. McElvaney NG, Wilcox PG, Churg A, et al. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease. Arch Intern Med 1988;148:2231-6.
24. Le-Quang B, Calmels P, Valayer-Chaleat E, et al. Dantrolene and pleural effusion: case report and review of literature. Spinal Cord 2004;42:317-20.
25. Tzanakis N, Bouros D, Siafakas N. Eosinophilic pleural effusion due to gliclazide. Respir Med 2000;94:94.
26. Trisolini R, Dore R, Biagi F, et al. Eosinophilic pleural effusion due to mesalamine: report of a rare occurrence. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:288-91.
27. Moufarrege G, Frank E, Carstens DD. Eosinophilic exudative pleural effusion after initiation of tizanidine treatment: a case report. Pain Med 2003;4:85-90.
28. Debourdeau PM, Djezzar S, Estival JL, et al. Life-threatening eosinophilic pleuropericardial effusion related to vitamins B5 and H. Ann Pharmacother 2001;35:424-6.
29. Behnia M, Dowdeswell I, Vakili S. Pleural fluid and serum eosinophilia: association with fluoxetine hydrochloride. South Med J 2000;93:611-3.
30. Kuwahara T, Hamada M, Inoue Y, et al. Warfarin-induced eosinophilic pleurisy. Intern Med 1995;34:794-6.
31. Huggins JT, Sahn SA. Drug-induced pleural disease. Clin Chest Med 2004;25:141-53.